More reads

• Coalition attacks Trump plan to end drug rebates, calling it a ‘big pharma bailout.’ (STAT Plus)
• AbbVie to cut 178 jobs, three years after $6 billion Stemcentrx deal. (San Francisco Business Times)
• Precision Bio's IPO raises $126 million for pipeline of gene-edited drugs. (Xconomy)
• EASL 2019 preview - Viking and Spring Bank abstracts pique early interest. (EP Vantage)